Correspondence 0001213900-23-004108 from Lucy Scientific Discovery, Inc. (LSDIF) (CIK 0001865127)
Lucy Scientific Discovery, Inc. (LSDIF) (CIK 0001865127)
Date: Jan. 20, 2023 · CIK: 0001865127 · Accession: 0001213900-23-004108
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-262296
Letter
Lucy Scientific Discovery Inc.
301-1321 Blanshard Street
Victoria, British Columbia V8W 0B6 Canada
January 20, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Kristin Lochhead, Terence O’Brien, Ada D. Samerento and Jeffery Gabor
Re: Lucy Scientific Discovery Inc.
Registration Statement on Form S-1
SEC File No. 333-262296
Filed January 21, 2022, as amended March 4, 2022, November 14, 2022, December 5, 2022, December 15, 2022, January 9, 2023 and January 18, 2023
Ladies and Gentlemen:
Reference is made to two letters, each filed as correspondence via EDGAR on January 19, 2023, in which both we and the underwriter requested the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-262296) for January 23, 2023, at 5:00 p.m. Eastern Time, or as soon thereafter as practicable, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw both our and the underwriter’s requests for acceleration of the effective date.
Please direct any questions or comments concerning this request to Joseph Walsh of Troutman Pepper Hamilton Sanders LLP at (212) 704-6030.
LUCY SCIENTIFIC DISCOVERY INC.
By: /s/ Christopher McElvany
Name: Christopher McElvany
Title: President and Chief Executive Officer
Cc: Andrew Hulsh, Troutman Pepper Hamilton Sanders LLP
Joseph Walsh, Troutman Pepper Hamilton Sanders LLP
Andrew M. Tucker, Nelson Mullins Riley & Scarborough LLP
Show Raw Text
CORRESP
1
filename1.htm
Lucy Scientific Discovery Inc.
301-1321 Blanshard Street
Victoria, British Columbia V8W 0B6 Canada
January 20, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Kristin Lochhead, Terence O’Brien, Ada D. Samerento
and Jeffery Gabor
Re:
Lucy Scientific Discovery Inc.
Registration Statement on Form S-1
SEC File No. 333-262296
Filed January 21, 2022, as amended March 4, 2022, November 14, 2022, December 5, 2022, December 15, 2022, January 9, 2023 and January 18, 2023
Ladies and Gentlemen:
Reference
is made to two letters, each filed as correspondence via EDGAR on January 19, 2023, in which both we and the underwriter requested
the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-262296) for
January 23, 2023, at 5:00 p.m. Eastern Time, or as soon thereafter as practicable, in accordance with Rule 461 under the Securities Act
of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally
withdraw both our and the underwriter’s requests for acceleration of the effective date.
Please direct any questions
or comments concerning this request to Joseph Walsh of Troutman Pepper Hamilton Sanders LLP at (212) 704-6030.
LUCY SCIENTIFIC DISCOVERY INC.
By:
/s/ Christopher McElvany
Name:
Christopher McElvany
Title:
President and Chief Executive Officer
Cc:
Andrew Hulsh, Troutman Pepper Hamilton Sanders LLP
Joseph Walsh, Troutman Pepper Hamilton Sanders LLP
Andrew M. Tucker, Nelson Mullins Riley & Scarborough LLP